196 related articles for article (PubMed ID: 24342913)
1. VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model.
Denbeigh JM; Nixon BA; Hudson JM; Puri MC; Foster FS
Ultrasound Med Biol; 2014 Feb; 40(2):389-99. PubMed ID: 24342913
[TBL] [Abstract][Full Text] [Related]
2. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma.
Wei S; Fu N; Sun Y; Yang Z; Lei L; Huang P; Yang B
Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557
[TBL] [Abstract][Full Text] [Related]
3. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
[TBL] [Abstract][Full Text] [Related]
4. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
[TBL] [Abstract][Full Text] [Related]
5. Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements.
Rix A; Palmowski M; Gremse F; Palmowski K; Lederle W; Kiessling F; Bzyl J
Ultrasound Med Biol; 2014 Oct; 40(10):2468-75. PubMed ID: 25023096
[TBL] [Abstract][Full Text] [Related]
6. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced molecular ultrasound differentiates endoglin genotypes in mouse embryos.
Denbeigh JM; Nixon BA; Lee JJ; Jerkic M; Marsden PA; Letarte M; Puri MC; Foster FS
Angiogenesis; 2015 Jan; 18(1):69-81. PubMed ID: 25298070
[TBL] [Abstract][Full Text] [Related]
8. Contrast imaging in mouse embryos using high-frequency ultrasound.
Denbeigh JM; Nixon BA; Puri MC; Foster FS
J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867243
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
[TBL] [Abstract][Full Text] [Related]
10. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.
Turco S; Tardy I; Frinking P; Wijkstra H; Mischi M
Phys Med Biol; 2017 Mar; 62(6):2449-2464. PubMed ID: 28240217
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.
Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK
Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176
[TBL] [Abstract][Full Text] [Related]
12. Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?
Wang S; Herbst EB; Mauldin FW; Diakova GB; Klibanov AL; Hossack JA
Invest Radiol; 2016 Dec; 51(12):758-766. PubMed ID: 27654582
[TBL] [Abstract][Full Text] [Related]
13. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis.
Rychak JJ; Graba J; Cheung AM; Mystry BS; Lindner JR; Kerbel RS; Foster FS
Mol Imaging; 2007; 6(5):289-96. PubMed ID: 18092513
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound molecular imaging of vascular endothelial growth factor receptor 2 expression for endometrial receptivity evaluation.
Liu H; Chen Y; Yan F; Han X; Wu J; Liu X; Zheng H
Theranostics; 2015; 5(2):206-17. PubMed ID: 25553109
[TBL] [Abstract][Full Text] [Related]
15. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.
Warram JM; Sorace AG; Saini R; Umphrey HR; Zinn KR; Hoyt K
J Ultrasound Med; 2011 Jul; 30(7):921-31. PubMed ID: 21705725
[TBL] [Abstract][Full Text] [Related]
16. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature.
Korpanty G; Carbon JG; Grayburn PA; Fleming JB; Brekken RA
Clin Cancer Res; 2007 Jan; 13(1):323-30. PubMed ID: 17200371
[TBL] [Abstract][Full Text] [Related]
17. Effects of acoustic radiation force on the binding efficiency of BR55, a VEGFR2-specific ultrasound contrast agent.
Frinking PJ; Tardy I; Théraulaz M; Arditi M; Powers J; Pochon S; Tranquart F
Ultrasound Med Biol; 2012 Aug; 38(8):1460-9. PubMed ID: 22579540
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound molecular imaging of transient acute myocardial ischemia with a clinically translatable P- and E-selectin targeted contrast agent: correlation with the expression of selectins.
Hyvelin JM; Tardy I; Bettinger T; von Wronski M; Costa M; Emmel P; Colevret D; Bussat P; Lassus A; Botteron C; Nunn A; Frinking P; Tranquart F
Invest Radiol; 2014 Apr; 49(4):224-35. PubMed ID: 24442162
[TBL] [Abstract][Full Text] [Related]
19. Molecular and functional ultrasound imaging of breast tumors.
Bzyl J; Lederle W; Palmowski M; Kiessling F
Eur J Radiol; 2012 Sep; 81 Suppl 1():S11-2. PubMed ID: 23083550
[No Abstract] [Full Text] [Related]
20. Ultrasound Molecular Imaging With BR55, a Predictive Tool of Antiangiogenic Treatment Efficacy in a Chemo-Induced Mammary Tumor Model.
Helbert A; Von Wronski M; Colevret D; Botteron C; Padilla F; Bettinger T; Tardy I; Hyvelin JM
Invest Radiol; 2020 Oct; 55(10):657-665. PubMed ID: 32229739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
